Abstract

Inhibition of programmed cell death pathways is frequently observed in cancer cells where it functions to facilitate tumor progression. However, some proteins involved in the regulation of cell death function dichotomously to both promote and inhibit cell death depending on the cellular context. As such, understanding how cell death proteins are regulated in a context-dependent fashion in cancer cells is of utmost importance. We have uncovered evidence that cellular FLICE-like Inhibitory Protein (c-FLIP), a well-known anti-apoptotic protein, is often downregulated in tumor tissue when compared to adjacent normal tissue. These data argue that c-FLIP may have activity distinct from its canonical role in antagonizing cell death. Interestingly, we have discovered that detachment from extracellular matrix (ECM) serves as a signal to elevate c-FLIP transcription and that oncogenic signaling blocks ECM-detachment-induced c-FLIP elevation. In addition, our data reveal that downregulation of c-FLIP promotes luminal filling in mammary acini and that c-FLIP overexpression in cancer cells inhibits colony formation in cells exposed to ECM-detachment. Taken together, our study reveals an unexpected, non-apoptotic role for c-FLIP during ECM-detachment and raises the possibility that c-FLIP may have context-dependent roles during tumorigenesis.

Highlights

  • Inhibition of programmed cell death pathways is frequently observed in cancer cells where it functions to facilitate tumor progression

  • Our findings describe an unexpected role for c-FLIPL during extracellular matrix (ECM)-detachment that may account for the observed downregulation of c-FLIPL in breast cancers

  • Our results demonstrate that the ECM-detachmentmediated elevation in c-FLIPL expression is counteracted by oncogenic signaling through activation of the PI(3) K/Akt pathway

Read more

Summary

Introduction

Inhibition of programmed cell death pathways is frequently observed in cancer cells where it functions to facilitate tumor progression. We have uncovered evidence that cellular FLICE-like Inhibitory Protein (c-FLIP), a well-known anti-apoptotic protein, is often downregulated in tumor tissue when compared to adjacent normal tissue. These data argue that c-FLIP may have activity distinct from its canonical role in antagonizing cell death. While there are multiple c-FLIP variants known to be generated by alternative splicing, each variant has two DED domains and can interact with other DED-containing proteins through DED:DED interactions These interactions drive the best characterized function of c-FLIP: its capacity to inhibit the activation of receptor-mediated cell death ­pathways[2]. Our results unveil a possible mechanism to explicate why breast tumors often have diminished c-FLIP levels and why low c-FLIP levels correlate with poor patient outcomes for breast cancer patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call